In previous studies, researchers have demonstrated that TMEM200A is involved in the progression of pancreatic cancer (Tan, Schaffalitzky de Muckadell & Joergensen, 2020) and acute myeloid leukemia (AML) (Nie et al., 2022). Here, TMEM200A is linked to acute myeloid leukemia.